# A Study to Determine the Safety and Immunogenicity of Co-administration of the Candidate Influenza Vaccine MVA-NP+M1 and Seasonal Influenza Vaccine

> **NCT01465035** · PHASE1 · COMPLETED · sponsor: **University of Oxford** · enrollment: 24 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** TIV and MVA-NP+M1
- **BIOLOGICAL:** Saline placebo and seasonal influenza vaccine TIV

## Key facts

- **NCT ID:** NCT01465035
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2012-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01465035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01465035, "A Study to Determine the Safety and Immunogenicity of Co-administration of the Candidate Influenza Vaccine MVA-NP+M1 and Seasonal Influenza Vaccine". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01465035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*